Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Zebrafish help understand genetic causes of skin pigment disorders like albinism.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

New compounds were made that are promising for prostate cancer therapy.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Finasteride and dutasteride might lower melanoma risk.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Suppressing ODC activity reduces tumor growth in hair follicles.

Baricitinib works better than methotrexate for severe alopecia areata.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Three compounds from Dadap leaves may help treat hair loss.

KDML105 bran extract may help with hair growth and prevent hair loss.

5AR inhibitors like finasteride and dutasteride improve hair growth and slow hair loss in male pattern baldness.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.